Generation bio to present at the 2022 jefferies cell and genetic medicine summit

Cambridge, mass., sept. 22, 2022 (globe newswire) -- generation bio co. (nasdaq: gbio), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, announced that the company will participate in a fireside chat at the 2022 jefferies cell & genetic medicine summit on thursday, september 29th at 10:30 a.m. et in new york.

GBIO Ratings Summary

GBIO Quant Ranking